Dechert advised Roche and Foundation Medicine in their partnership. Roche and Foundation Medicine announced their partnership with Gustave Roussy, the leading cancer center in Europe, to...
You must be a Standard 1 Year member to access this content.
Fréget Glaser & Associés assisted the Novartis laboratory in its appeal against the Competition Authority’s decision. The Roche laboratory was advised by Dechert LLP. Novartis has...
You must be a Standard 1 Year member to access this content.
Dechert advised Havea. PwC Société d’Avocats carried out tax due diligence on behalf of Havea Group. Havea Group has announced that it has entered into exclusive negotiations...
You must be a Standard 1 Year member to access this content.
Dechert advised Chiesi Farmaceutici S.p.A. Gide Loyrette Nouel represented BNP Paribas. Amryt Pharma was advised by Cooley. Italian pharmaceutical company Chiesi Farmaceutici has signed a definitive agreement to acquire Amryt Pharma in...
You must be a Standard 1 Year member to access this content.
The Paul Hastings team advised the shareholders of Carso, while Dechert advised ArchiMed on the deal. ArchiMed, a leading investment firm exclusively dedicated to the healthcare...
You must be a Standard 1 Year member to access this content.
IN BRIEF: Allen & Overy, Dechert, advised on the matter. Allen & Overy advised Crédit Mutuel Equity with a team including Fr??ic Moreau (Corporate M&A), Romy...
You must be a Standard 1 Year member to access this content.
